Analyst Price Target is C$6.20
▲ +13.55% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for NorthWest Health Prop Real Est Inv Trust in the last 3 months. The average price target is C$6.20, with a high forecast of C$7.00 and a low forecast of C$5.75. The average price target represents a 13.55% upside from the last price of C$5.46.
Current Consensus is
Hold
The current consensus among 2 investment analysts is to hold stock in NorthWest Health Prop Real Est Inv Trust. This rating changed within the last month from a Moderate Buy consensus rating.